Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Weller

Showing results (151-160 of 938) with videos related to

Pageof 94
Sort By:
Histology and Histopathology|December 15, 2012
Expression of integrins αvβ3 and αvβ5 and their ligands in primary and secondary central nervous system neoplasmsMichel Mittelbronn, Arne Warth, Richard Meyermann, et al.
Oncology|October 9, 2008
Procarbazine and CCNU as initial treatment in gliomatosis cerebriMartin Glas, Katja Rasch, Dorothee Wiewrodt, et al.
European Neurology|November 18, 2014
Clinically isolated neurosarcoidosis: a recommended diagnostic pathSusanne Wegener, Michael Linnebank, Roland Martin, et al.
Journal of Neuro-Oncology|November 6, 2004
Intracranial metastatic esthesioneuroblastoma responsive to temozolomideWolfgang Wick, Antje Wick, Wilhelm Küker, et al.
Cases Journal|September 5, 2008
Vertebral artery dissection presenting with ispilateral acute C5 and C6 sensorimotor radiculopathy: A case reportGhazaleh Tabatabai, Wolfgang Schöber, Ulrike Ernemann, et al.
Expert Opinion on Investigational Drugs|August 5, 2020
Proteasome inhibition for the treatment of glioblastomaPatrick Roth, Warren P Mason, Paul G Richardson, et al.
Neuro-Oncology|August 29, 2014
Differential regulation of TGF-β-induced, ALK-5-mediated VEGF release by SMAD2/3 versus SMAD1/5/8 signaling in glioblastomaKatharina Seystahl, Isabel Tritschler, Emese Szabo, et al.
Oncology Research and Treatment|April 16, 2014
Neuropathological characteristics of progression after prolonged response to bevacizumab in multifocal hemangioblastomaKatharina Seystahl, Michael Weller, Oliver Bozinov, et al.
Journal of Neuro-Oncology|August 25, 2014
Letter to the Editor: "The role of imaging in the management of progressive glioblastoma. A systematic review and evidence-based clinical practice guideline" [J Neurooncol 2014; 118:435-460]Karl-Josef Langen, Jörg C Tonn, Michael Weller, et al.
Biochemical Pharmacology|September 25, 2003
Involvement of protein kinase Cdelta and extracellular signal-regulated kinase-2 in the suppression of microglial inducible nitric oxide synthase expression by N-[3,4-dimethoxycinnamoyl]-anthranilic acid (tranilast)Michael Platten, Katrin Eitel, Jörg Wischhusen, et al.
Pageof 94

Showing results (151-160 of 938) with videos related to

Sort By:
Pageof 94
Histology and Histopathology|December 15, 2012
Expression of integrins αvβ3 and αvβ5 and their ligands in primary and secondary central nervous system neoplasmsMichel Mittelbronn, Arne Warth, Richard Meyermann, et al.
Oncology|October 9, 2008
Procarbazine and CCNU as initial treatment in gliomatosis cerebriMartin Glas, Katja Rasch, Dorothee Wiewrodt, et al.
European Neurology|November 18, 2014
Clinically isolated neurosarcoidosis: a recommended diagnostic pathSusanne Wegener, Michael Linnebank, Roland Martin, et al.
Journal of Neuro-Oncology|November 6, 2004
Intracranial metastatic esthesioneuroblastoma responsive to temozolomideWolfgang Wick, Antje Wick, Wilhelm Küker, et al.
Cases Journal|September 5, 2008
Vertebral artery dissection presenting with ispilateral acute C5 and C6 sensorimotor radiculopathy: A case reportGhazaleh Tabatabai, Wolfgang Schöber, Ulrike Ernemann, et al.
Expert Opinion on Investigational Drugs|August 5, 2020
Proteasome inhibition for the treatment of glioblastomaPatrick Roth, Warren P Mason, Paul G Richardson, et al.
Neuro-Oncology|August 29, 2014
Differential regulation of TGF-β-induced, ALK-5-mediated VEGF release by SMAD2/3 versus SMAD1/5/8 signaling in glioblastomaKatharina Seystahl, Isabel Tritschler, Emese Szabo, et al.
Oncology Research and Treatment|April 16, 2014
Neuropathological characteristics of progression after prolonged response to bevacizumab in multifocal hemangioblastomaKatharina Seystahl, Michael Weller, Oliver Bozinov, et al.
Journal of Neuro-Oncology|August 25, 2014
Letter to the Editor: "The role of imaging in the management of progressive glioblastoma. A systematic review and evidence-based clinical practice guideline" [J Neurooncol 2014; 118:435-460]Karl-Josef Langen, Jörg C Tonn, Michael Weller, et al.
Biochemical Pharmacology|September 25, 2003
Involvement of protein kinase Cdelta and extracellular signal-regulated kinase-2 in the suppression of microglial inducible nitric oxide synthase expression by N-[3,4-dimethoxycinnamoyl]-anthranilic acid (tranilast)Michael Platten, Katrin Eitel, Jörg Wischhusen, et al.
Pageof 94